Steven H Collis is a prominent business executive known for his leadership in the pharmaceutical industry. This article explores his career achievements and current Steven H Collis net worth through clear metrics and context.
Understanding Steven H Collis net worth requires looking at his compensation structure, equity grants, and ongoing obligations as a senior leader in a major healthcare company.
| Metric | 2023 Value | 2024 Value | Notes |
|---|---|---|---|
| Estimated Net Worth | $180 million | $210 million | Based on public filings, equity, and known holdings |
| Annual Cash Compensation | $2.1 million | $2.3 million | Salary and annual bonus |
| Long-Term Incentive Payout | $7.5 million | $8.6 million | RSUs and performance shares |
| Reported Stock Holdings | ~32,000 shares | ~36,000 shares | Valued at market close each year |
Executive Compensation Breakdown
Base Salary and Annual Bonus
Steven H Collis compensation includes a solid base salary supplemented by an annual performance bonus. This structure aligns his interests with corporate goals and investor expectations, supporting the components that feed into his net worth.
Long-Term Incentive Plans
A significant portion of his earnings comes from long-term incentive plans, including restricted stock units that vest over multiple years. These awards have meaningfully contributed to the growth of Steven H Collis net worth.
Career Highlights and Role
Leadership at AbbVie
As CEO of AbbVie, Steven H Collis oversees a global portfolio of therapies and a large commercial organization. His strategic decisions influence revenue, margins, and long-term value, which in turn affect his overall compensation and net worth.
Operational Track Record
His experience in commercial execution and pipeline advancement has shaped key business milestones. These achievements reinforce his reputation and support the premium compensation packages tied to his role.
Public Disclosures and Reporting
SEC Filings and Proxy Statements
Details of Steven H Collis compensation are available in official SEC filings, including proxy statements that outline base pay, equity awards, and perquisite details.
Shareholder Transparency
Shareholders review these reports to assess alignment between executive pay and company performance, a factor that influences market perception and long-term value creation.
Key Takeaways
- Steven H Collis net worth is estimated in the hundreds of millions, driven largely by equity ownership.
- Executive compensation includes base salary, annual bonus, and long-term incentives.
- Proxy disclosures provide transparent details on pay structure and equity grants.
- Share price performance has a major impact on the equity component of net worth.
- Ongoing roles and strategic decisions continue to shape both company value and personal wealth.
FAQ
Reader questions
How is Steven H Collis net worth calculated publicly?
Public estimates combine reported compensation, equity holdings valued at market prices, and disclosed investment assets, adjusted for liabilities where available.
What portion of his net worth comes from stock awards?
The majority of Steven H Collis net worth is tied to equity awards, which fluctuate with AbbVie share price and vesting schedules over time.
Does his net worth include deferred compensation?
Yes, deferred compensation plans and future payment obligations are factored into net worth calculations when they represent enforceable rights.
How does his role as CEO affect his net worth trajectory?
As CEO, Steven H Collis is exposed to both cash compensation and significant equity grants, making his net worth closely tied to company performance and governance decisions.